Boston Scientific Corp [NYSE: BSX] gained 1.75% or 1.75 points to close at $101.49 with a heavy trading volume of 9284917 shares.
The daily chart for BSX points out that the company has recorded 12.07% gains over the past six months.
If we look at the average trading volume of 8.12M shares, BSX reached to a volume of 9284917 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Boston Scientific Corp [BSX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BSX shares is $120.59 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BSX stock is a recommendation set at 1.37. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Boston Scientific Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2025. The new note on the price target was released on April 16, 2025, representing the official price target for Boston Scientific Corp stock. Previously, the target price had yet another raise to $108, while Deutsche Bank analysts kept a Buy rating on BSX stock.
The Average True Range (ATR) for Boston Scientific Corp is set at 2.09, with the Price to Sales ratio for BSX stock in the period of the last 12 months amounting to 8.55. The Price to Book ratio for the last quarter was 6.76, with the Price to Cash per share for the same quarter was set at 0.56. Price to Free Cash Flow for BSX in the course of the last twelve months was 49.82 with Quick ratio for the last quarter at 0.88.
Trading performance analysis for BSX stock
Boston Scientific Corp [BSX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.45. With this latest performance, BSX shares dropped by -3.21% in over the last four-week period, additionally plugging by 12.07% over the last 6 months – not to mention a rise of 31.11% in the past year of trading.
Boston Scientific Corp [BSX]: A deeper dive into fundamental analysis
Boston Scientific Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.88 and a Current Ratio set at 1.45.
Boston Scientific Corp [BSX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BSX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Boston Scientific Corp go to 14.06%.
An analysis of Institutional ownership at Boston Scientific Corp [BSX]
The top three institutional holders of BSX stocks are: FMR LLC with ownership of 141.46 million shares, which is approximately 9.6192%. VANGUARD GROUP INC, holding 129.87 million shares of the stock with an approximate value of $$10.0 billion in BSX stocks shares; and VANGUARD GROUP INC, currently with $$9.74 billion in BSX stock with ownership which is approximately 8.5964%.
